Laza Medical Secures Up To $160M in Series B Funding

Laza Medical, the Campbell, CA-based Shifamed portfolio company developing AI-powered robotic imaging solutions for cardiac interventions, has raised $160 million in a Series B funding round.

The round was led by GE HealthCare with participation from Unorthodox Ventures, PA MedTech, and AMED.

The company plans to use the funding to expand its operations and development efforts, with a focus on advancing its imaging technology for cardiovascular procedures.

What is Laza Medical?

Laza Medical develops AI powered robotic imaging systems for cardiovascular interventions. Its technology combines artificial intelligence, and robotics to provide image guidance during complex cardiac procedures.

Read More:Traversal Raises $120M at a $1 Billion Valuation

The system is designed to help medical teams navigate and guide procedures with greater precision, and consistency. It also aims to simplify imaging workflows and reduce the need for highly specialised imaging expertise.

As cardiovascular procedures become more complex, hospitals need reliable imaging solutions that can support doctors, and other care teams. Laza Medical aims to address this need through its combination of AI and robotics.

How Much Funding Has Laza Medical Raised?

Laza Medical has secured up to $160 million in its Series B funding round.

The company has not disclosed its total funding raised to date or details of previous funding rounds.

Who Invested in Laza Medical’s Series B?

The Series B round was led by GE HealthCare.

Other participating investors include:

• Unorthodox Ventures
• PA MedTech
• AMED

Laza Medical is also a portfolio company of Shifamed, LLC.

Why the Funding Matters

Laza Medical will use the funding to expand its operations and support product development.

The investment will help advance its AI-powered robotic imaging technology, which is designed to simplify cardiac procedures, improve imaging guidance, and address resource constraints in catheterization laboratories.

The company is also working towards enabling future robotic-assisted cardiovascular interventions.

Who founded Laza Medical?

Laza Medical was founded by Amr Salahieh. It is a privately held portfolio company of Shifamed, LLC, and is headquartered in Campbell, California.

"The future of cardiac intervention must be one where access, consistency, and quality of care are no longer barriers to better outcomes," stated Jyoti Gera, CEO of Cardiovascular and Interventional Solutions, Advanced Imaging Solutions at GE HealthCare.

"The cath lab is poised for a fundamental evolution, and intelligent imaging powered by AI will play a defining role in what comes next," said Amr Salahieh, Founder, and Board Chairman at Laza Medical. "As we reimagine the role of imaging in interventional care, we are grateful for the strong support from our investors, which validates our approach, and reinforces our conviction that this solution will streamline processes, reduce variability and ultimately improve the quality, and reach of cardiac procedures."

Market and Business Growth

Laza Medical is developing technology for cardiac catheterization laboratories, where medical teams perform procedures to diagnose and treat cardiovascular conditions.

Its platform combines AI and robotics to provide consistent image guidance during complex interventions. The technology aims to help care teams manage increasingly complex procedures while addressing the shortage of specialised imaging expertise.

What Happens Next?

Laza Medical plans to expand its operations and continue developing its AI-powered robotic imaging solutions.

Its focus will remain on improving image guidance for cardiovascular procedures and advancing technology that could support greater automation in cardiac interventions.

Read More:Cowboy Raises $5M to Expand Its AI Agent App Store